Pill Diet

Buy Phentermine Alternative Without Prescription – Pharmaco Labs Announces Diet Pill Has No Side Effects

rich — Sun, 20 May 2012 10:45:32 +0000

PharmaCo Labs makers of PhenObestin 37.5 – safe non prescription alternative to prescription weight loss drugs such as Phentermine and Adipex.

Germantown, MD (PRWEB) May 17, 2012

SupplementsToWeight Loss LLC – PharmaCo Labs announces addition of PhenObestin 37.5 to their line of products. PhenObestin 37.5, a non-prescription weight loss pill from PharmaCo Labs, is proven to help people lose weight as quickly as Phentermine or Adipex. However, unlike Phentermine or Adipex, PhenObestin 37.5 has no side effects.

Unlike other diet drugs, PhenObestin 37.5 does not contain any controversial herbs such as hoodia which may cause harmful side effects. Instead, PhenObestin 37.5 contains only safe, pharmaceutical-grade ingredients, produced in a cGMP-FDA compliant laboratory based in Indianapolis, IN.

The secret to PhenObestin’s effectiveness is the mixture of ingredients. One key ingredient is Phenylethylamine, the feel-good chemical in chocolate that boosts your brain’s dopamine levels while reducing your appetite. It increases the level of activity in your brain, and may help to reduce the mood swings and depression caused by dieting.

Another key ingredient is Theobromine Anhydrous, also from the cocoa plant, which increases metabolism. In fact, it increases metabolism even more than Phentermine does! In addition, it helps to cleanse your system of toxins and fatty deposits by acting as a diuretic, flushing water through your body to rinse away impurities.

As you can see, both of these ingredients offer important benefits to dieters. But the magic happens with the correct combination of the two ingredients. This potent combination not only reduces hunger, but you feel happy and alert while the pounds melt away.

Finally, Yohimbine 99% HCL is included to increase blood circulation, allowing the other two ingredients to more easily travel throughout the body and be absorbed where they are needed. This extract of Yohimbine bark helps to break down fat and, working in conjunction with the other ingredients, stimulate adrenoreceptors. This powerful ingredient attacks the stubborn pockets of fat in the belly and around your vital organs.

Other ingredients also stimulate fat burning and provide you with additional energy and mental clarity to offset the foggy feeling and lethargy so common to dieters.

The effectiveness of PhenObestin 37.5 is not purely theoretical. It has been on the market since 2009, and used by over 1 million people in the United States, Australia, and the United Kingdom. As an over-the-counter drug, it has been used by many regular people, but it has also been used by a number of doctors for themselves and their patients. All of these users report that they have achieved positive weight loss results quickly and easily with PhenObestin 37.5.

The results seen by any individual will, of course, depend on their particular circumstances. The highest amount of fat loss is seen by people who are eating nutrition-packed meals of fresh fruits and vegetables such as salads or green smoothies, as well as exercising to build muscle mass. While the scale may not indicate overall weight loss, you’ll see and feel the difference as your clothing fits better, your waistline shrinks, and you no longer have flabby arms or legs.

The more muscle mass you add, the more calories you’ll burn, even when you’re not actively working out. So, while it may take longer to see results on the scale, you can be sure that there is important change happening inside your body. Once you stop adding muscle mass, the pounds will fall away even faster than they would have otherwise, and you’ll quickly overtake the people who haven’t been exercising for total weight loss achieved. Plus, it will be healthy weight loss, rather than the dangerous loss of muscle caused by crash diets that results in yo-yo weight loss and gain as your metabolism spirals downward.

Since exercising is so important to successful weight loss, dieters appreciate the added energy and focus available with PhenObestin 37.5. Getting to the gym or taking a brisk walk around the block no longer becomes an effort of willpower, but an enjoyable use of your healthier body.
For more information, contact Georgiy Kharchenko at 800-935-6312.

Please remember that buying prescription phentermine without prescription is illegal.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebbuy-phentermine/adipex-online/prweb9515460.htm

Fighting Fat: FDA Panel OKs Arena Diet Pill

rich — Fri, 11 May 2012 06:39:43 +0000

On overweight man’s waistline. (Photo credit: Wikipedia)

In a move that may herald a new era in fighting fat, an FDA advisory voted 18-to-4 to recommend the agency approve the Arena Pharmaceutical diet pill, which is known as Lorqess. This marks the second time in three months that an FDA panel has decided the benefits of reducing the growing American waist line outweigh the various risks that have delayed this latest round of fat-fighting drugs from finding their way to medicine cabinets.

In February, an FDA advisory committee voted overwhelmingly in favor of the Qnexa diet pill developed by Vivus. Of course, the recommendations are not a guarantee the FDA will issue approvals. But the back-to-back endorsements – and lopsided votes – suggest the safety concerns that plagued the drugmakers during earlier panel meetings have been sufficiently addressed and increase the odds the FDA will approve the pills.

Unlike the September 2010 advisory panel meeting, Arena was able to overcome concerns about a theoretical risk of an increase in cancer; valvulopathy, which is heart valve damage, and cardiovascular adverse events. Some committee members discussing the possbility of requiring echocardiograms before patients are prescribed Lorqess, given that an increased risk CV events could not be ruled out. Most likely, the FDA would require a post-approval outcomes study.

A related question is whether the FDA would require a REMS, or Risk Evaluation and Mitigation Strategy. A REMS was proposed for Vivus pill, but a key issue with that drug is the risk of birth defects, which does not plague the Arena pill. Nonetheless, the FDA has been consistently cautious in viewing diet pills because these drugs are likely to be widely and, perhaps, inappropriately used, suggesting REMS programs are likely to be employed.

Nonetheless, fighting fat is a key priority for public health agencies. The percentage of obese Americans, which is already a hefty 36 percent, is expected to swell to 42 percent by 2030. And by then, 11 percent could be severely obese, which is deemed to be about 100 or more pounds over a healthy weight, compared with 6 percent two years ago, according to a study released earlier this week in the American Journal of Preventive Medicine (read here).

However, one public health advocate says the FDA bent overbackwards toward this end. Diana Zuckerman, who is president of the National Research Center for Women & Families, a nonpartisan, nonprofit think tank, says the FDA’s Center for Drug Evaluation & Research “has been under pressure to approve more drugs to reduce obesity. The pressure is from the many groups focused on reducing obesity. Their mantra has been that the risks of obesity are much greater than the risks of these drugs.”

“The consumer and public health advocates, in contrast, point out that the benefits of these drugs are very limited. Study after study show that many patients stop taking the drugs after a few weeks or months, and even those they stay on for six months or more tend to stop taking the drugs as soon as the benefits plateau. Then, they gain the weight back again. In other words, the drugs have the same long-term impact as yo-yo dieting,” she writes in an e-mail.

Lorqess “did not meet the weight loss standards that FDA requires, and has risks of suicidal thoughts, neurological problems and possibly breast cancer. CDER knew their usual Advisory Committee was unlikely to recommend approval, so the agency added more clinicians,” she concludes. “The clinicians almost always want ‘more options’ and voted to recommend approval for this ineffective, possibly dangerous drug.”

Arena shares rise on favorable diet pill review

rich — Thu, 10 May 2012 08:21:54 +0000

WASHINGTON (AP) — Shares of Arena Pharmaceuticals Inc. continued to rise Wednesday, a day after federal health regulators issued a surprisingly favorable assessment of the company’s previously rejected diet pill.

The Food and Drug Administration denied approval for Arena‘s lorcaserin in 2010 after scientists raised concerns about tumors that developed in animals studied with the drug, among other safety concerns. The company resubmitted the drug with additional data earlier this year, hoping for a better outcome.

In a review posted online Tuesday, the FDA said new analysis submitted by the company suggests “negligible risk to human subjects,” of tumors. Questions remain about the drug’s effects on heart valves, an issue that frequently plagues weight-loss pills. Scientists also raised concerns that the drug can increase the risk of high blood pressure in diabetics.

On Thursday the FDA will ask a panel of outside experts to discuss and vote on the drug’s safety and efficacy. The vote is nonbinding but usually guides FDA decisions. BMO analyst Jim Birchenough upgraded Arena to “outperform,” on the FDA review.

“The briefing documents are clearly positive for Arena and suggest a much higher likelihood of approval than previously thought. We cannot rule out some restriction in diabetics but, in general, we believe that a positive panel recommendation is likely.”

Arena shares rose 19 cents, or 5.5 percent, to $3.61 in morning trading.

Arena is one of three small drug makers racing to launch the first new prescription diet drug in more than a decade. The FDA has already rejected each of the drugs once and all three companies have resubmitted their products for a second review. Earlier this year, rival Vivus Inc. won a surprising endorsement from an FDA panel for its drug Qnexa, raising expectations for Arena and Orexigen Therapeutics Inc., the third company in the race.

Weight loss with Arena’s drug was modest, with a mean reduction of 3.1 percent over a year. More than 37 percent of patients lost 5 percent of their weight or more, which was enough to meet FDA standards for effectiveness. By comparison mean weight loss with Qnexa was 11 percent, with more than 83.5 percent of patients losing 5 percent of their weight or more.

FDA revisits safety of Arena Pharma's diet pill

rich — Wed, 09 May 2012 10:17:50 +0000

WASHINGTON (AP) — Federal health regulators are revisiting questions about the risk of tumors and heart problems with an experimental diet pill from Arena Pharmaceuticals, which was previously rejected for similar safety concerns.

But documents posted Tuesday suggest the company may have provided the government with enough new information to alleviate those concerns.

The Food and Drug Administration denied approval for Arena’s lorcaserin in 2010 after scientists raised concerns about tumors that developed in animals studied with the drug. The company resubmitted the drug with additional data earlier this year, hoping for a better outcome.

FDA reviewers said increased hormone levels likely contributed to noncancerous tumors seen in studies of female rats. But reviewers said the evidence suggests “negligible risk to human subjects.”

Questions remain about the drug’s effects on heart valves, an issue that frequently plagues weight loss pills. The FDA said pooled results from several studies provided by the company show statistically worrisome levels of heart valve damage.

The agency will ask a panel of advisers Thursday whether Arena has provided enough data to address those and other risks.

The FDA is not required to follow the advice of its advisers, though it usually does.

The quest for a blockbuster weight loss drug has eluded nearly every major pharmaceutical firm over the last four decades.

With U.S. obesity rates nearing 35 percent of the adult population, many doctors say new pharmaceutical treatments are needed. And Wall Street analysts estimate that even a modestly effective drug has blockbuster potential.

But a long line of prescription weight loss offerings have been associated with safety problems, most notably the fen-phen combination, which was linked to heart damage in 1997. The cocktail of phentermine and fenfluramine was a popular weight loss combination prescribed by doctors, though it was never approved by FDA.

Arena is one of three small drugmakers racing to launch the first new prescription diet drug in more than a decade. The FDA has already rejected each of the drugs once and all three companies have resubmitted their products for a second review. Earlier this year, rival Vivus Inc. won a surprising endorsement from an FDA panel for its drug Qnexa, raising expectations for Arena and Orexigen Therapeutics Inc., the third company in the race.

Shares of San Diego-based Arena Pharmaceuticals Inc. rose 44 cents, or 16.2 percent, to $3.16 in afternoon trading.

FDA revisits safety of Arena Pharma's diet pill

rich — Tue, 08 May 2012 23:12:20 +0000

But documents posted Tuesday suggest the company may have provided the government with enough new information to alleviate those concerns.

FDA reviewers said increased hormone levels likely contributed to noncancerous tumors seen in studies of female rats. But reviewers said the evidence suggests “negligible risk to human subjects.”

The agency will ask a panel of advisers Thursday whether Arena has provided enough data to address those and other risks.

The FDA is not required to follow the advice of its advisers, though it usually does.

The quest for a blockbuster weight loss drug has eluded nearly every major pharmaceutical firm over the last four decades.

Arena is one of three small drugmakers racing to launch the first new prescription diet drug in more than a decade. The FDA has already rejected each of the drugs once and all three companies have resubmitted their products for a second review. Earlier this year, rival Vivus Inc. won a surprising endorsement from an FDA panel for its drug Qnexa, raising expectations for Arena and Orexigen Therapeutics Inc., the third company in the race.

Shares of San Diego-based Arena Pharmaceuticals Inc. rose 44 cents, or 16.2 percent, to $3.16 in afternoon trading.

Arena's stock rises ahead of diet pill hearing

rich — Tue, 08 May 2012 21:42:00 +0000

Arena Pharmaceuticals of La Jolla saw its stock price spike on Tuesday two days before the FDA will reconsider whether it should approve the company’s experimental diet pill lorcaserin. The spike appears to have occurred primarily because a new FDA staff report reduces concerns about cancer risks from the drug.

Arena — which typically trades for a few dollars — closed at $3.42, up 70 cents on the day, or 25.7 percent.

There was mixed speculation in the media Tuesday about Arena’s chances of winning FDA approval. The agency turned the company down in 2010, citing concerns about an increased risk of tumors and heart problems.

Bloomberg News reported on Tuesday that, “The risk of brain cancer is negligible, FDA staff said in a report Tuesday ahead of a meeting on the obesity drug. An FDA analysis of data also found benign breast cancer was more common than the malignant form at all dose levels of the medicine, chemically known as lorcaserin. The report included a request for advisers to weigh the cancer risks and raised questions about the effectiveness of the pill.

But the Associated Press (story) reported that the onus is still on Arena to prove that there are not unacceptable health risks with the drug, which could become the first new federally approved diet pill to hit the market in about a decade.

About one-third of the American population is obese. A federal report released Monday said that figure could rise to 42 percent by 2030.

Diet Doc Weight Loss Announces a Doctor Formulated Diet Pill or Appetite Suppressant Free of Charge For Patients …

rich — Sun, 06 May 2012 23:48:22 +0000

Diet Doc Weight Loss announces a doctor formulated diet pill and appetite suppressant for patients joining their medical, weight loss program. They are offering the pills during the period May 4th – 6th free of charge. The diet pills require a doctors prescription.

Los Angeles, CA (PRWEB) May 04, 2012

Diet Doc Weight Loss announces a new doctor-designed diet pill and appetite suppressant for patients joining their medical weight loss program during the period of May 4th-6th free of charge, a $55 value.

The diet pills / appetite suppressants were created by weight loss doctors and are part of a comprehensive weight loss program aimed at shaving 25 pounds per month. Diet Doc patients are able to realize these incredible results with the use of specific medications that are safe, yet highly effective. The medications are geared towards rapid weight loss.

Diet Doc also formulated weight loss shakes and a unique weight loss oil (flavorless) used to make salad dressing and/or cooking that is clinically proven to burn fat instead of storing this oil as fat within the human body. This is because the oil is metabolized differently than olive oil or any type of cooking oil used.

The Diet Doc Diet Pills cannot be found in stores or with other doctors. Diet Doctors specifically formulated the diet pills and weight loss products with rapid weight loss in mind.

Diet Doc Diet Doctors customize a weight loss program for each person based on their health history, age, gender and lifestyle. By customizing a diet for each person, the patient receives a powerful diet program, along with using specific medications and appetite suppressants to get the results they are looking for. This type of approach is not done by other doctors as typically it’s labor intensive. Diet Doc’s mission is if they do right by each person, they hope that people will refer friends and family.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9477562.htm

Diet Doc Weight Loss Announces a Doctor Formulated Diet Pill or Appetite Suppressant Free of Charge For Patients …

rich — Sat, 05 May 2012 06:43:17 +0000

Chameleons on the jukebox.

5 Deadliest Diet Trends: Pills That Really Can Kill

rich — Thu, 19 Apr 2012 09:23:08 +0000

Sizing down: risky business

June is just around the corner, and bridal blogs and magazines are filled with suggestions for nervous brides hoping to shed pounds before the big day.

Scary new weight loss drugs are winning market approval and the world — including Forbes — is talking about the über-creepy feeding tube diet.

But any time you try to speed weight loss beyond the doctor-recommended 1 to 2 pounds a week, you take risks.

So now it’s time to look at how far we’re willing to go to lose weight – and what risks we’re willing to take. Here are the latest diet trends, and a realistic assessment of the dangers they pose.

1. The Japanese Weight Loss Pill

What it is: A supplement imported from Japan known as Xiushentang, marketed as Japan Rapid Weight Loss Diet Pills in three colos: green, yellow, and blue. Ten days ago, the FDA issued a strong warning, stating that the medications contain the chemical phenolphthalein and the weight loss drug sibutramine.

Why it’s dangerous: Phenolphthalein is listed by the FDA as a suspected carcinogen, and sibutramine, sold as the brand name diet drug Meridia, was pulled from the market in 2010 for raising the risk of heart attack and stroke.

2. Clen Fat Burner

What it is: Clenbuterol is a steroid used to treat repiratory illnesses in horses. It’s not approved for human use, but is taken illegally by athletes and models to boost muscle mass and trigger weight loss. It made headlines last summer when athletes were banned from the Pan Am games after testing positive for “Clen,” as it’s familiarly known.

Why it’s dangerous: Clenbuterol hasn’t been tested in humans, but there’s evidence from animal studies that it’s taken up by muscle tissues throughout the body, and therefore can damage the heart muscle. It’s illegal to use it in human consumption, yet it’s easily available from many pharmaceutical websites with a quick Google search. There’s also the fact that we might be taking clenbuterol unknowingly; this summer the FDA warned that up to 40 percent of imported meat had tested positive for clenbuterol, carried over from animal use.

3. The Brazilian Diet Pill

What it is: Nutritional supplements imported from Brazil, sold under the name of Emagrece Sim and Herbaslim. The long list of ingredients includes Librium, the antidepressant Prozac, and the stimulant Fenproporex. Since 2006,when the FDA issued a warning against these drugs, news reports have sounded the alarm.

Why it’s dangerous: The combination of uppers and downers can cause severe mood swings. Allure Magazine reported on models who were experiencing extreme personality changes, as well as other odd symptoms, such as a hypersensitivity to touch. Meanwhile the drugs continue to sell briskly via websites that tout their amazing weight loss benefits.

4. Qnexa and Successors

What it is: The supposed future blockbuster diet drug Qnexa is just the first of several weight loss drugs in final phase testing. All are combinations of existing drugs, making for a faster approval process. Contrave, from Orexigen, is a mix of bupropion, an antidepressant also used to quit smoking, and naltrexone, used for alcoholism and addition to opiates. Arena pharmaceuticals’ Lorcaserin, an appetite suppressant, may finally be approved by the FDA later this year.

Why it’s dangerous: Honestly, any drug that messes with metabolism and mood is likely to have tricky side effects. Last year the FDA sent Contrave back into testing, requiring long-term studies to make sure it — like many diet drugs that work as stimulants — doesn’t raise heart attack risk. Lorcaserin, which had much better safety in studies, was also sent back by the FDA for further testing due to concerns about heart valve damage.

5. The K-E Diet

What it is: Forever more to be known as the “feeding tube diet” or “nose drip diet,” the K-E method involves inserting a naso-gastric tube through the nose, through which a nutrient solution is delivered directly to the stomach. As reported by Forbes, the K-E method limits calorie intake to approximately 800 calories a day, as you eat no food while you’re doing it. There’s not a lot more to say about this crazy new diet trend that hasn’t been said. Popularized by brides looking to drop the proverbial 1o pounds in two weeks (except this diet promises a 20-pound loss in 10 days), the procedure involves finding a doctor who will oversee the procedure.

Why it’s dangerous: Well, it involves inserting a feeding tube down the nose into the stomach. There’s considerable risk of inflammation and infection. The process puts the body into a metabolic state known as ketosis, which means burning fat instead of calories. Technically it works to lose weight, but it puts considerable stress on the liver and kidneys. And consider the questionable credentials of any doctor willing to do this procedure on an otherwise healthy patient. There’s just no other way to describe this trend than courting disaster.

FDA will take 3 more months to review diet pill

rich — Wed, 11 Apr 2012 05:31:21 +0000

[unable to retrieve full-text content]FDA will take 3 more months to review diet pill Associated Press Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Updated 03:39 p.m., Monday, April 9, 2012 WASHINGTON (AP) — Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa …